| US 7,498,405 B2 | ||
| Halogen-substituted thienyl compounds | ||
| Yigong Ge, So. San Francisco, Calif. (US); Matthew J. Taylor, San Francisco, Calif. (US); Eldon E. Baird, Half Moon Bay, Calif. (US); Roland W. Burli, San Francisco, Calif. (US); Jacob A. Kaizerman, Redwood City, Calif. (US); Amanda E. Martin, San Francisco, Calif. (US); and Brie Cadman, Napa, Calif. (US) | ||
| Assigned to GeneSoft Pharmaceuticals, Inc., South San Francisco, Calif. (US) | ||
| Filed on Jun. 02, 2006, as Appl. No. 11/446,598. | ||
| Application 11/446598 is a continuation of application No. 10/132887, filed on Apr. 24, 2002, granted, now 7,122,626. | ||
| Claims priority of provisional application 60/286454, filed on Apr. 26, 2001. | ||
| Prior Publication US 2006/0287247 A1, Dec. 21, 2006 | ||
| Int. Cl. C07K 5/10 (2006.01) | ||
| U.S. Cl. 530—330 [530/329; 530/331; 549/29; 549/41] | 12 Claims |
1. A thienyl compound having the formula:
 wherein
Th is
 wherein each of R1, R2, and R3 is H, F, Cl, Br, I or a substituted or unsubstituted (C1-C12)alkyl group, with the proviso that at least one of R1, R2, and R3 is F, Cl, Br or I, but R1, R2, and R3 being otherwise independently variable;
s is 3 or 4;
t is 0; and
N(R20)2 is selected from the group consisting of
 |